Zobrazeno 1 - 10
of 74
pro vyhledávání: '"O. Naismith"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ann Henry, Shama Hassan, Alison Tree, Emma Hall, O. Naismith, Clare Cruickshank, Clare Griffin, John Staffurth, Nuria Porta, Stephanie Brown, Isabel Syndikus, Nicola Snelson, Helen Mayles
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 25, Iss, Pp 22-28 (2020)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • PIVOTALboost evaluates benefits/toxicity of pelvic node RT and focal boost dose escalation. • Unfavourable intermediate/high risk and bulky local disease are most likely to benefit. • Functional MRI imaging is used to select patien
Autor:
Helen Mossop, Sarah L. Gulliford, P. Mayles, Clare Griffin, John Staffurth, Christopher D Scrase, Helen Mayles, Clare Cruickshank, Miguel Panades, Anna Wilkins, Chris Parker, Jamie Dean, David P. Dearnaley, Emma Hall, Vincent Khoo, Isabel Syndikus, Julia Murray, Simon Thomas, O. Naismith
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 21, Iss, Pp 77-84 (2020)
Clinical and Translational Radiation Oncology, Vol 21, Iss, Pp 77-84 (2020)
Highlights • Dosimetric benefits to the penile bulb was seen in patients treated with IGRT and reduced CTV-PTV margins. • Patients who had a lower planned dose to the penile bulb reported less erectile dysfunction. • A threshold mean penile bul
Autor:
C. South, Helen Mayles, K Roberts, Emma Hall, Shama Hassan, Sarah L. Gulliford, CHHiP Investigators, Catharine H. Clark, Khoo, David P. Dearnaley, M. Bidmead, O. Naismith
Publikováno v:
Clinical Oncology. 31:611-620
Aims The CHHiP trial investigated the use of moderate hypofractionation for the treatment of localised prostate cancer using intensity-modulated radiotherapy (IMRT). A radiotherapy quality assurance programme was developed to assess compliance with t
Autor:
Vincent Khoo, Stuart McCracken, John J. McGrath, Hashim U. Ahmed, Derek J. de Solla Price, Bijan Khoubehi, Nicola Anyamene, O. Naismith, Cathryn Brock, Emily Day, Martin Evans, Azman Ibrahim, Giles Hellawell, Kamalram Thippu Jayaprakash, John Staffurth, Catherine Heath, R. Pearson, Stephen Mangar, Martin J. Connor, Johanna Sukumar, Denise Sheehan, Naveed Sarwar, Dolan Basak, Manal Kumar, Alison Falconer, Bhavan Prasad Rai, Shiva Gayadeen, Michael Gonzalez, Natalia Klimowska-Nassar, Mathias Winkler, Tim Dudderidge, Iqbal S. Shergill, Francesca Fiorentino, Taimur T. Shah, Gail Horan, Katarzyna Smigielska
Publikováno v:
BMJ Open
BMJ Open, Vol 11, Iss 2 (2021)
BMJ Open, Vol 11, Iss 2 (2021)
IntroductionSurvival in men diagnosed with de novo synchronous metastatic prostate cancer has increased following the use of upfront systemic treatment, using chemotherapy and other novel androgen receptor targeted agents, in addition to standard and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afd6f4b4da88ad47cb06c223e2da89ca
PD-0758 Fraction Size Sensitivity (α/β ratios) For Late Genitourinary Toxicities After Prostate EBRT
Autor:
O. Naismith, Annie Gao, Douglas Brand, Sarah L. Gulliford, Anna Wilkins, Isabel Syndikus, D. Dearnaley, Sarah C. Brüningk, N. van As, Emma Hall, Alison Tree
Publikováno v:
Radiotherapy and Oncology. 161:S589-S590
Autor:
A.C. Tree, E. Hall, P. Ostler, H. van der Voet, A. Loblaw, W. Chu, D. Ford, S. Tolan, S. Jain, A. Martin, J. Staffurth, P. Camilleri, K. Kancherla, J. Frew, D.H. Brand, A. Chan, I.S. Dayes, S. Brown, J. Pugh, S. Burnett, A. Dufton, C. Griffin, M. Mahmud, O. Naismith, N. van As, O.B. of the
Publikováno v:
Radiotherapy and Oncology. 161:S196-S197
Autor:
Clare Griffin, John Staffurth, Chris Parker, David P. Dearnaley, Sarah L. Gulliford, Vincent Khoo, O. Naismith, Isabel Syndikus, Clare Cruickshank, Jamie Dean, P. Mayles, Emma Hall, Miguel Panades, Simon Thomas, A. Baker, Julia Murray, Helen Mayles, Christopher D Scrase, Helen Mossop
Publikováno v:
Radiotherapy and Oncology
Highlights • Introduction of daily online prostate IGRT was feasible in a national randomised trial. • Dosimetric benefits seen in patients treated with IGRT and reduced CTV-PTV margins. • Overall side effect profiles were acceptable in all gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a15f84e60956b859a7f278cd5fc299c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.